Related Experiment Video

Updated: May 7, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis

Tao Zhang1, Wenjie Guo, Yang Yang

  • 11] State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China [2].

Scientific Reports
|October 4, 2013
PubMed

Insights

The Src homology 2 domain-containing tyrosine phosphatase 2 (SHP-2) in CD4(+) T cells is crucial for preventing melanoma progression. Lower SHP-2 levels correlate with increased metastasis and inflammatory cytokine release, highlighting its tumor-suppressing role in immunity.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • The role of Src homology 2 domain-containing tyrosine phosphatase 2 (SHP-2) in cancer is complex, with reported tumor-promoting and tumor-suppressing functions.
  • The specific involvement of SHP-2 in anti-tumor immunity, particularly within T cells, remains largely undetermined.

Purpose of the Study:

  • To investigate the role of SHP-2 in CD4(+) T cells during melanoma development and metastasis.
  • To elucidate the mechanisms by which SHP-2 influences the tumor microenvironment and immune response in melanoma.

Main Methods:

  • Analysis of phosphorylated SHP-2 levels in CD4(+) T cells from murine melanoma models and human melanoma specimens.
  • Generation of CD4(+) T cell-specific SHP-2 knockout mice to assess its impact on melanoma progression.
  • Measurement of cytokine release and myeloid-derived suppressor cell (MDSC) accumulation in tumor-bearing mice.
  • In vivo experiments using IL-6-neutralizing antibodies.

Main Results:

  • Phosphorylated SHP-2 levels progressively decreased in tumor-associated CD4(+) T cells during melanoma development in mice and humans.
  • CD4(+) T cell-specific deletion of SHP-2 accelerated melanoma metastasis.
  • SHP-2 deficiency in CD4(+) T cells led to increased IL-6 release and enhanced MDSC accumulation.
  • Neutralization of IL-6 reduced MDSC accumulation and inhibited tumor growth in SHP-2 deficient mice.

Conclusions:

  • SHP-2 in CD4(+) T cells acts as a critical suppressor of melanoma progression and metastasis.
  • SHP-2 signaling in CD4(+) T cells modulates the tumor microenvironment, influencing cytokine production and MDSC infiltration.

More Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...